Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dalia Dawoud

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 2, 2024
Linking Reimbursement to Patient Benefits for Advanced Therapy Medicinal Products and Other High-Cost Innovations: Policy Recommendations for Outcomes-Based Agreements in EuropeTuba Saygın Avşar, Jamie Elvidge, Claire Hawksworth, et al.
Frontiers in Pharmacology|November 28, 2022
Institutionalizing health technology assessment in Egypt: Situational analysis and roadmapPilar Pinilla-Dominguez, Shorouk Taha, Hugh McGuire, et al.
Frontiers in Pharmacology|January 29, 2024
Advancing the use of real world evidence in health technology assessment: insights from a multi-stakeholder workshopRavinder Claire, Jamie Elvidge, Shahid Hanif, et al.
Pharmacoeconomics|March 25, 2022
Target Trial Emulation for Transparent and Robust Estimation of Treatment Effects for Health Technology Assessment Using Real-World Data: Opportunities and ChallengesManuel Gomes, Nick Latimer, Marta Soares, et al.
Research in Social & Administrative Pharmacy : RSAP|May 19, 2019
Generosity, collegiality, and scientific accuracy when writing and reviewing original researchShane P Desselle, Aleda M Chen, Mohamed Amin, et al.
Frontiers in Neurology|April 3, 2023
Participating in innovative medicines initiative funded neurodegenerative disorder projects-An impact analysis conducted as part of the NEURONET projectClaire Hawksworth, Fatima Salih, Katharine Cresswell, et al.
Pharmacoeconomics|December 18, 2020
Common Problems, Common Data Model Solutions: Evidence Generation for Health Technology AssessmentSeamus Kent, Edward Burn, Dalia Dawoud, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 13, 2025
ELEVATE-GenAI: Reporting Guidelines for the Use of Large Language Models in Health Economics and Outcomes Research: An ISPOR Working Group ReportRachael L Fleurence, Dalia Dawoud, Jiang Bian, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 10, 2025
A Taxonomy of Generative AI in HEOR: Concepts, Emerging Applications, and Advanced Tools - An ISPOR Working Group ReportRachael L Fleurence, Xiaoyan Wang, Jiang Bian, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 14, 2026
The Use of Generative Artificial Intelligence in Systematic Literature Reviews: A Rapid Review of the LiteratureRachael L Fleurence, Riaz Qureshi, Rakesh Aggarwal, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 2, 2024
Linking Reimbursement to Patient Benefits for Advanced Therapy Medicinal Products and Other High-Cost Innovations: Policy Recommendations for Outcomes-Based Agreements in EuropeTuba Saygın Avşar, Jamie Elvidge, Claire Hawksworth, et al.
Frontiers in Pharmacology|November 28, 2022
Institutionalizing health technology assessment in Egypt: Situational analysis and roadmapPilar Pinilla-Dominguez, Shorouk Taha, Hugh McGuire, et al.
Frontiers in Pharmacology|January 29, 2024
Advancing the use of real world evidence in health technology assessment: insights from a multi-stakeholder workshopRavinder Claire, Jamie Elvidge, Shahid Hanif, et al.
Pharmacoeconomics|March 25, 2022
Target Trial Emulation for Transparent and Robust Estimation of Treatment Effects for Health Technology Assessment Using Real-World Data: Opportunities and ChallengesManuel Gomes, Nick Latimer, Marta Soares, et al.
Research in Social & Administrative Pharmacy : RSAP|May 19, 2019
Generosity, collegiality, and scientific accuracy when writing and reviewing original researchShane P Desselle, Aleda M Chen, Mohamed Amin, et al.
Frontiers in Neurology|April 3, 2023
Participating in innovative medicines initiative funded neurodegenerative disorder projects-An impact analysis conducted as part of the NEURONET projectClaire Hawksworth, Fatima Salih, Katharine Cresswell, et al.
Pharmacoeconomics|December 18, 2020
Common Problems, Common Data Model Solutions: Evidence Generation for Health Technology AssessmentSeamus Kent, Edward Burn, Dalia Dawoud, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 13, 2025
ELEVATE-GenAI: Reporting Guidelines for the Use of Large Language Models in Health Economics and Outcomes Research: An ISPOR Working Group ReportRachael L Fleurence, Dalia Dawoud, Jiang Bian, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 10, 2025
A Taxonomy of Generative AI in HEOR: Concepts, Emerging Applications, and Advanced Tools - An ISPOR Working Group ReportRachael L Fleurence, Xiaoyan Wang, Jiang Bian, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 14, 2026
The Use of Generative Artificial Intelligence in Systematic Literature Reviews: A Rapid Review of the LiteratureRachael L Fleurence, Riaz Qureshi, Rakesh Aggarwal, et al.
Pageof 8